Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases.
Overview
- Department of Pathology, University of Colorado Anschutz, Aurora, Colorado
- Department of Neurosurgery, University of Colorado Anschutz, Aurora, Colorado
- Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz, Aurora, Colorado
- Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz, Aurora, Colorado
Abstract
The central nervous system (CNS) is a common site of metastasis for both non–small cell and small cell lung cancer, yet the therapeutic strategies to prevent and decrease lung cancer brain metastases (BM) remain limited. Tyrosine kinase inhibitors have shown promising results in increasing overall response in BM, owing to their brain penetrance and increased effectiveness; however, their use is limited to a small group of tumors carrying specific oncogenic drivers. Among these, inhibitors targeting neurotrophic tyrosine receptor kinases (NTRK) are showing promising effects in reducing CNS metastases in cancers driven by gene rearrangements of these drugs’ targets. However, wild-type NTRKs are susceptible to activation by their canonical ligands, which are expressed throughout the BM niche and can, in a paracrine manner, activate NTRK function in cancer cells. In this study, we show that NTRKs are expressed in primary tumors, BM, and lung cancer cells with various driver mutations expressing wild-type NTRK2 (WT-TrkB). We demonstrate that WT-TrkB activates downstream signaling and proliferation in response to exogenous brain-derived neurotrophic factor (BDNF) and conditioned media from reactive astrocytes known to secrete BDNF in the brain niche. Importantly, the FDA-approved NTRK inhibitor entrectinib blocked BDNF and astrocyte-induced survival pathways in multiple lung cancer cell lines, decreased their proliferation in vitro, and effectively prevented BM colonization and progression in vivo without significant effects on extracranial disease. Thus, these studies suggest that brain-dependent activation of NTRK is critical for BM of WT-NTRK+ lung cancers; therefore, NTRK inhibitors can be used to target nonfusion NTRK function to prevent or decrease BM.
Significance: These studies demonstrate that NTRK wild-type receptors are important drivers of brain metastatic colonization and progression in different subtypes of lung cancer, independent of their driver alterations. Thus, they provide a rationale to expand the use of FDA-approved NTRK inhibitors with brain penetrance for the prevention of CNS metastases.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data, not to its authors' code: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE200563, at NCBI GEO; found in “Publicly available data analysis”
Data Availability
All data and protocols described in the article will be made available upon reasonable request within 6 years of publication.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 10 authors, 16 MeSH terms, 5 funders, 46 references, 4 RRIDs.
Cite
This paper
Contreras-Zárate, M. J., Jaramillo-Gómez, J. A., Marquez-Ortiz, R. A., Pham, T. C., Koliavas, S. N., Ormond, D. R., Navarro, A. C., Nemenoff, R. A., Camidge, D. R., & Cittelly, D. M. (2026). Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases. Cancer research communications, 6(8), 1850-1861. https://
BibTeX
@article{contreraszarate
author = {Contreras-Zárate, Maria J and Jaramillo-Gómez, Jenny A and Marquez-Ortiz, R Alejandro and Pham, Trinh C and Koliavas, Stella N and Ormond, D Ryan and Navarro, Andre C and Nemenoff, Raphael A and Camidge, D Ross and Cittelly, Diana M},
title = {{Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases}},
journal = {Cancer research communications},
year = {2026},
month = aug,
volume = {6},
number = {8},
pages = {1850--1861},
publisher = {American Association for Cancer Research},
issn = {2767-9764},
doi = {10.1158/
url = {https://
pmid = {42480609},
pmcid = {PMC13436848}
}
RIS
TY - JOUR
AU - Contreras-Zárate, Maria J
AU - Jaramillo-Gómez, Jenny A
AU - Marquez-Ortiz, R Alejandro
AU - Pham, Trinh C
AU - Koliavas, Stella N
AU - Ormond, D Ryan
AU - Navarro, Andre C
AU - Nemenoff, Raphael A
AU - Camidge, D Ross
AU - Cittelly, Diana M
TI - Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases
T2 - Cancer research communications
J2 - Cancer Res Commun
PY - 2026
DA - 2026/
VL - 6
IS - 8
SP - 1850
EP - 1861
SN - 2767-9764
PB - American Association for Cancer Research
DO - 10.1158/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1158/
"type": "article-journal",
"title": "Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain Metastases",
"container-title": "Cancer research communications",
"author": [
{
"family": "Contreras-Zárate",
"given": "Maria J"
},
{
"family": "Jaramillo-Gómez",
"given": "Jenny A"
},
{
"family": "Marquez-Ortiz",
"given": "R Alejandro"
},
{
"family": "Pham",
"given": "Trinh C"
},
{
"family": "Koliavas",
"given": "Stella N"
},
{
"family": "Ormond",
"given": "D Ryan"
},
{
"family": "Navarro",
"given": "Andre C"
},
{
"family": "Nemenoff",
"given": "Raphael A"
},
{
"family": "Camidge",
"given": "D Ross"
},
{
"family": "Cittelly",
"given": "Diana M"
}
],
"container-title-short":
"volume": "6",
"issue": "8",
"page": "1850-1861",
"DOI": "10.1158/
"PMID": "42480609",
"PMCID": "PMC13436848",
"ISSN": "2767-9764",
"publisher": "American Association for Cancer Research",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
1
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41467-026-73726-5
- Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastases.Journal: Nature communicationsIn common: other condition, mouse, cellular / molecular, 5 references, 4 authors
- [2] doi:10.1038/s41419-026-08807-w [code]
- Single-cell profiling reveals distinct populations of tumor-associated macrophages and metastatic tumor cells in breast cancer brain metastasis.Journal: Cell death & diseaseIn common: other condition, mouse, cellular / molecular, 2 references
- [3] doi:10.1186/s11658-026-00957-1
- Lactate-activated astrocytes promote NSCLC brain metastasis through extracellular vesicle-mediated miR-8085/
TRIM67/ ELK1 signaling axis. Journal: Cellular & molecular biology lettersIn common: other condition, cellular / molecular, 2 references - [4] doi:10.1126/sciadv.aed6825
- SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain.Journal: Science advancesIn common: mouse, cellular / molecular, 2 references
- [5] doi:10.1038/s41556-026-01910-2
- Characterizing the metabolomes of microglia, astrocytes and neurons in ageing and Alzheimer's brains.Journal: Nature cell biologyIn common: mouse, cellular / molecular, 2 references
- [6] doi:10.1523/eneuro.0386-25.2026 [code]
- Astrocyte-Derived PTPRZ1 Regulates Excitatory Synapse Density in the Mouse Cortex.Journal: eNeuroIn common: mouse, cellular / molecular, 2 references
- [7] doi:10.1073/pnas.2532488123 [code]
- Control of microglial dynamics by the Arp2/
3 complex and the autism- and schizophrenia-associated protein CYFIP1. Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: mouse, cellular / molecular, 2 references - [8] doi:10.1523/jneurosci.2002-24.2026
- Astrocyte TrkB.T1 Deficiency Disrupts Glutamatergic Synaptogenesis and Astrocyte-Synapse Interactions.Journal: The Journal of neuroscience : the official journal of the Society for NeuroscienceIn common: mouse, cellular / molecular, 2 references
- [9] doi:10.1073/pnas.2614867123 [code]
- Glucocorticoid receptors in oligodendrocyte precursor cells regulate hippocampal network plasticity and stress-induced behavior in mice.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: mouse, cellular / molecular, 2 references
- [10] doi:10.1073/pnas.2426990123
- Endothelial KLF4 depletion drives age-related neurovascular dysfunction and neuropsychiatric impairment.Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: mouse, cellular / molecular, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.